Richard H. White

Treatment of heparin-induced thrombocytopenia.

Validation of the Canadian clinical probability model for acute venous thrombosis.

Protein C, antithrombin, and venous thromboembolism incidence: a prospective population-based study.

Risk factors for venous thromboembolism after total hip and knee replacement surgery.

Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism.

DVT prophylaxis and anticoagulation in the surgical patient.

Not all butterfly eyes are created equal: rhodopsin absorption spectra, molecular identification, and localization of ultraviolet-, blue-, and green-sensitive rhodopsin-encoding mRNAs in the retina of Vanessa cardui.

Low-molecular-weight heparins: are they all the same?

Pharmacotherapy of heparin- induced thrombocytopenia.

The epidemiology of venous thromboembolism.

Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.

The retina of Manduca sexta: rhodopsin expression, the mosaic of green-, blue- and UV-sensitive photoreceptors, and regional specialization.

Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures.

Polarized light helps monarch butterflies navigate.

Low-molecular-weight heparin-induced thrombocytopenia in a child.

Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology.

Patient self-management of oral anticoagulation.

Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review.

Adult stemmata of the butterfly Vanessa cardui express UV and green opsin mRNAs.

ICD-9-CM codes poorly indentified venous thromboembolism during pregnancy.

Men had greater risk for recurrent venous thromboembolism than women.

Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996.

The Alport nephropathy: clinicopathological correlations.

Electronic alerts to prevent venous thromboembolism.

Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis.

Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults.

Age as a risk factor for venous thromboembolism after major surgery.

Do patients followed in anticoagulation clinics for antiphospholipid syndrome meet criteria for the disorder?

Venous thromboembolism after spinal cord injury: incidence, time course, and associated risk factors in 16,240 adults and children.

Incidence of venous thromboembolism and its effect on survival among patients with common cancers.

Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.

Mandating coverage of biologic therapies for rheumatic disease: where evidence and politics meet.

Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.

Racial and gender differences in the incidence of recurrent venous thromboembolism.

The incidence and case-fatality rates of acute biliary, alcoholic, and idiopathic pancreatitis in California, 1994-2001.

Incidence of venous thromboembolism and the impact on survival in breast cancer patients.

Fixed-dose, weight-adjusted, unfractionated heparin was as effective and safe as low-molecular-weight heparin for venous thromboembolism.

Venous thromboembolism in ovarian cancer.

Co-morbidity is a strong predictor of early death and multi-organ system failure among patients with acute pancreatitis.

Epidemiology of venous thromboembolism in 9489 patients with malignant glioma.

Compost impacts on dissolved organic carbon and available nitrogen and phosphorus in turfgrass soil.

Seasonal dynamics of soil micronutrients in compost-amended bermudagrass turf.

An economic model of adverse events and costs for oral anticoagulants used for atrial fibrillation.

Additional uses for the classic matrix band.

The effects of race/ethnicity and sex on the risk of venous thromboembolism.

Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?

Venous ultrasound testing for suspected thrombosis: incidence of significant non-thrombotic findings.

Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.

Death due to recurrent thromboembolism among younger healthier individuals hospitalized for idiopathic pulmonary embolism.

N-of-1 trials of expensive biological therapies: a third way?

Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.

Shostakovich versus the Central Committee: the power of music.

Risk of fatal pulmonary embolism was 0.49 per 100 person-years after discontinuing anticoagulant therapy for venous thromboembolism.

Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival.

Risk of cancer among rheumatoid arthritis patients in California.

Epidemiology of cancer-related venous thromboembolism.

Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.

Effects of race and ethnicity on the incidence of venous thromboembolism.

Testing for thrombophilia: pitfalls, limitations, and marginal impact on treatment duration recommendations.

Long-term incidence of death due to thromboembolic disease among patients with unprovoked pulmonary embolism.

How valid is the ICD-9-CM based AHRQ patient safety indicator for postoperative venous thromboembolism?

Re: Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?

Variations in perioperative warfarin management: outcomes and practice patterns at nine hospitals.

Effect of turfgrass establishment practices and composted biosolids on water quality.

Reproductive history, hormone replacement, and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology.

Surveillance for deep vein thrombosis and pulmonary embolism: recommendations from a national workshop.

The incidence of venous thromboembolism and its effect on survival among patients with primary bladder cancer.

Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States.

Venous thromboembolism in patients with acute leukemia, lymphoma, and multiple myeloma.

Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.

Therapeutics. Review: heparin and mechanical compression are similar in reducing postsurgical VTE risk, but heparin increases bleeding.

A population-based study of inferior vena cava filters in patients with acute venous thromboembolism.

Venous thromboembolism in uterine cancer.

Detection of pulmonary emboli with 99mTc-labeled anti-D-dimer (DI-80B3)Fab' fragments (ThromboView).

Photosynthetic photon flux density and phytochrome B interact to regulate branching in Arabidopsis.

Risk assessment models for cancer-associated venous thromboembolism.

A population-based comparison of the incidence of adverse outcomes after simultaneous-bilateral and staged-bilateral total knee arthroplasty.

Identifying risk factors for venous thromboembolism.

Accuracy and safety of (99m)Tc-labeled anti-D-dimer (DI-80B3) Fab' fragments (ThromboView®) in the diagnosis of deep vein thrombosis: a phase II study.

Mechanical and suboptimal pharmacologic prophylaxis and delayed mobilization but not morbid obesity are associated with venous thromboembolism after total knee arthroplasty: a case-control study.

Anticoagulation education: do patients understand potential medication-related emergencies?

Biomolecular markers of cancer-associated thromboembolism.

Improved Coding of Postoperative Deep Vein Thrombosis and Pulmonary Embolism in Administrative Data (AHRQ Patient Safety Indicator 12) After Introduction of New ICD-9-CM Diagnosis Codes.

Predictive Value of the Present-On-Admission Indicator for Hospital-acquired Venous Thromboembolism.

High variation between hospitals in vena cava filter use for venous thromboembolism.

ACP Journal Club. Scores poorly predict major bleeding (c-statistics ≤ 0.61) during oral anticoagulant therapy.

Splenectomy and the incidence of venous thromboembolism and sepsis in patients with immune thrombocytopenia.

Incidence of hospital-acquired venous thromboembolic codes in medical patients hospitalized in academic medical centers.

Younger age is associated with a higher risk of early periprosthetic joint infection and aseptic mechanical failure after total knee arthroplasty.

Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients.

Lymphoma and venous thromboembolism: influence on mortality.

Risk Predictors of Stroke and Mortality Following Ablation For Atrial Fibrillation: the California experience 2005-2009.